Build Your Comparison

Side-by-side financial analysis
NCRA logo
NCRA
LIXT logo
LIXT
KO logo
KO
Try popular comparisons:

Stock Comparison

NCRA vs LIXT vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NCRA
Nocera, Inc.

Packaged Foods

Consumer DefensiveNASDAQ • TW
Market Cap$2M
5Y Perf.-96.3%
LIXT
Lixte Biotechnology Holdings, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$76M
5Y Perf.-77.0%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$342.09B
5Y Perf.+65.1%

NCRA vs LIXT vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NCRA logoNCRA
LIXT logoLIXT
KO logoKO
IndustryPackaged FoodsBiotechnologyBeverages - Non-Alcoholic
Market Cap$2M$76M$342.09B
Revenue (TTM)$11M$0.00$49.28B
Net Income (TTM)$-4M$-7M$13.70B
Gross Margin1.4%61.7%
Operating Margin-25.2%29.3%
Forward P/E24.3x
Total Debt$7M$664K$45.49B
Cash & Equiv.$8M$5M$10.27B

NCRA vs LIXT vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NCRA
LIXT
KO
StockJan 21Jun 26Return
Nocera, Inc. (NCRA)1003.7-96.3%
Lixte Biotechnology… (LIXT)10023.0-77.0%
The Coca-Cola Compa… (KO)100165.1+65.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: NCRA vs LIXT vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIXT and KO are tied at the top with 3 categories each — the right choice depends on your priorities. The Coca-Cola Company is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
NCRA
Nocera, Inc.
The Secondary Option

NCRA plays a supporting role in this comparison — it may shine differently against other peers.

Best for: consumer defensive exposure
LIXT
Lixte Biotechnology Holdings, Inc.
The Income Pick

LIXT carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 1.19
  • Lower volatility, beta 1.19, Low D/E 6.1%, current ratio 3.88x
  • Beta 1.19, current ratio 3.88x
Best for: income & stability and sleep-well-at-night
KO
The Coca-Cola Company
The Growth Play

KO is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 1.9%, EPS growth 23.6%, 3Y rev CAGR 3.7%
  • 112.9% 10Y total return vs LIXT's -22.2%
  • 27.8% margin vs NCRA's -34.0%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthLIXT logoLIXT152.8% revenue growth vs NCRA's -35.2%
Quality / MarginsKO logoKO27.8% margin vs NCRA's -34.0%
Stability / SafetyLIXT logoLIXTBeta 1.19 vs NCRA's 1.68, lower leverage
DividendsKO logoKO2.6% yield; 56-year raise streak; the other 2 pay no meaningful dividend
Momentum (1Y)LIXT logoLIXT+407.2% vs NCRA's -83.7%
Efficiency (ROA)KO logoKO13.1% ROA vs LIXT's -96.3%, ROIC 15.8% vs -121.5%

NCRA vs LIXT vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NCRANocera, Inc.

Segment breakdown not available.

LIXTLixte Biotechnology Holdings, Inc.

Segment breakdown not available.

KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

NCRA vs LIXT vs KO — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGLIXT

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 5 of 6 comparable metrics.

KO and LIXT operate at a comparable scale, with $49.3B and $0 in trailing revenue. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to NCRA's -34.0%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$11M$0$49.3B
EBITDAEarnings before interest/tax-$3M-$7M$15.5B
Net IncomeAfter-tax profit-$4M-$7M$13.7B
Free Cash FlowCash after capex-$3M-$4M$12.6B
Gross MarginGross profit ÷ Revenue+1.4%+61.7%
Operating MarginEBIT ÷ Revenue-25.2%+29.3%
Net MarginNet income ÷ Revenue-34.0%+27.8%
FCF MarginFCF ÷ Revenue-26.9%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year-49.8%+12.1%
EPS Growth (YoY)Latest quarter vs prior year-3.9%+37.9%+18.2%
KO leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

NCRA leads this category, winning 2 of 3 comparable metrics.
MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…
Market CapShares × price$2M$76M$342.1B
Enterprise ValueMkt cap + debt − cash$2M$72M$377.3B
Trailing P/EPrice ÷ TTM EPS-0.84x-5.56x26.14x
Forward P/EPrice ÷ next-FY EPS est.24.31x
PEG RatioP/E ÷ EPS growth rate2.34x
EV / EBITDAEnterprise value multiple25.47x
Price / SalesMarket cap ÷ Revenue0.22x7.14x
Price / BookPrice ÷ Book value/share1.09x30.91x10.00x
Price / FCFMarket cap ÷ FCF64.59x
NCRA leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 6 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-132 for NCRA. LIXT carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to NCRA's 3.31x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs NCRA's 3/9, reflecting strong financial health.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity-132.0%-113.2%+41.1%
ROA (TTM)Return on assets-52.5%-96.3%+13.1%
ROICReturn on invested capital-70.0%-121.5%+15.8%
ROCEReturn on capital employed-35.9%-83.5%+17.3%
Piotroski ScoreFundamental quality 0–9347
Debt / EquityFinancial leverage3.31x0.06x1.33x
Net DebtTotal debt minus cash-$697,307-$4M$35.2B
Cash & Equiv.Liquid assets$8M$5M$10.3B
Total DebtShort + long-term debt$7M$664,491$45.5B
Interest CoverageEBIT ÷ Interest expense-1217.29x10.70x
KO leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

KO leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in KO five years ago would be worth $15,855 today (with dividends reinvested), compared to $343 for NCRA. Over the past 12 months, LIXT leads with a +407.2% total return vs NCRA's -83.7%. The 3-year compound annual growth rate (CAGR) favors KO at 12.0% vs NCRA's -51.6% — a key indicator of consistent wealth creation.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date-80.3%+82.3%+15.8%
1-Year ReturnPast 12 months-83.7%+407.2%+15.0%
3-Year ReturnCumulative with dividends-88.7%+5.6%+40.5%
5-Year ReturnCumulative with dividends-96.6%-77.3%+58.5%
10-Year ReturnCumulative with dividends-97.4%-22.2%+112.9%
CAGR (3Y)Annualised 3-year return-51.6%+1.8%+12.0%
KO leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than NCRA's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 96.1% from its 52-week high vs NCRA's 7.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5001.68x1.19x-0.15x
52-Week HighHighest price in past year$2.40$7.50$82.66
52-Week LowLowest price in past year$0.16$0.64$65.35
% of 52W HighCurrent price vs 52-week peak+7.0%+93.3%+96.1%
RSI (14)Momentum oscillator 0–10040.869.837.7
Avg Volume (50D)Average daily shares traded7.2M89K12.7M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 1 of 1 comparable metric.

KO is the only dividend payer here at 2.56% yield — a key consideration for income-focused portfolios.

MetricNCRA logoNCRANocera, Inc.LIXT logoLIXTLixte Biotechnolo…KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$86.29
# AnalystsCovering analysts48
Dividend YieldAnnual dividend ÷ price+2.6%
Dividend StreakConsecutive years of raises056
Dividend / ShareAnnual DPS$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.2%
KO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

KO leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NCRA leads in 1 (Valuation Metrics).

Best OverallThe Coca-Cola Company (KO)Leads 5 of 6 categories
Loading custom metrics...

NCRA vs LIXT vs KO: Key Questions Answered

8 questions · data-driven answers · updated daily

01

Is NCRA or LIXT or KO a better buy right now?

For growth investors, The Coca-Cola Company (KO) is the stronger pick with 1.

9% revenue growth year-over-year, versus -35. 2% for Nocera, Inc. (NCRA). The Coca-Cola Company (KO) offers the better valuation at 26. 1x trailing P/E (24. 3x forward), making it the more compelling value choice. Analysts rate The Coca-Cola Company (KO) a "Buy" — based on 48 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — NCRA or LIXT or KO?

Over the past 5 years, The Coca-Cola Company (KO) delivered a total return of +58.

5%, compared to -96. 6% for Nocera, Inc. (NCRA). Over 10 years, the gap is even starker: KO returned +112. 9% versus NCRA's -97. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — NCRA or LIXT or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

15β versus Nocera, Inc. 's 1. 68β — meaning NCRA is approximately -1234% more volatile than KO relative to the S&P 500. On balance sheet safety, Lixte Biotechnology Holdings, Inc. (LIXT) carries a lower debt/equity ratio of 6% versus 3% for Nocera, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — NCRA or LIXT or KO?

By revenue growth (latest reported year), The Coca-Cola Company (KO) is pulling ahead at 1.

9% versus -35. 2% for Nocera, Inc. (NCRA). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -11. 1% for Nocera, Inc.. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — NCRA or LIXT or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -25. 7% for Nocera, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -22. 3% for NCRA. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — NCRA or LIXT or KO?

In this comparison, KO (2.

6% yield) pays a dividend. NCRA, LIXT do not pay a meaningful dividend and should not be held primarily for income.

07

Is NCRA or LIXT or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

15), 2. 6% yield, +112. 9% 10Y return). Nocera, Inc. (NCRA) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +112. 9%, NCRA: -97. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between NCRA and LIXT and KO?

These companies operate in different sectors (NCRA (Consumer Defensive) and LIXT (Healthcare) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

KO pays a dividend while NCRA, LIXT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.